Predict your next investment

HEALTHCARE | Pharmaceuticals / Drugs
bebig.com

See what CB Insights has to offer

Stage

Acq - P2P | Acquired

About Eckert & Ziegler BEBIG

Eckert & Ziegler BEBIG manufactures and markets radioactive implants and medications used in the treatment of cancer. The company's implants are a localized treatment that kills the cancer without damaging the surrounding tissues.

Eckert & Ziegler BEBIG Headquarter Location

Rue Jules Bordet Zone Industrielle C

Seneffe, 7180,

Belgium

+32 (0) 64 520 811

Latest Eckert & Ziegler BEBIG News

Global $196.96 Bn Oncology Devices Market to 2025 & 2030: Major Players are Eckert & Ziegler BEBIG, Oncura, GE, Medtronic, Varian Medical Systems, Elekta, Theragenics, Accuray, and Roche Diagnostics

Aug 20, 2021

The global oncology devices market is expected to grow from $96.335 billion in 2020 to $110.44 billion in 2021 at a compound annual growth rate (CAGR) of 14.6%. The market is expected to reach $196.963 billion in 2025 at a CAGR of 16%. Oncology Devices Global Market Report 2021 provides the strategists, marketers and senior management with the critical information they need to assess the global oncology devices market. Major players in the oncology devices market are Eckert & Ziegler BEBIG, Oncura Inc, GE Healthcare, Medtronic plc, Varian Medical Systems Inc, Elekta AB, Theragenics Corporation, Accuray Incorporated, and Roche Diagnostics. The oncology devices market consists of sales of oncology devices and related services provided by the manufacturer of oncology devices. Oncology is a branch of science that investigates cancer cells. Oncology devices are medical devices used in the diagnosis, management, and treatment of cancer including breast cancer, lung cancer, pancreatic cancer, blood cancer, ovarian cancer, gastric cancer, skin cancer, kidney cancer, and brain tumor. Major companies in the market, research institutes and governments are continuously focusing on developing new devices to treat cancer patients. For instance, AIROS Medical Inc., a medical technology company based in the USA, launched AIROS 6 sequential compression therapy device and garment system to treat breast cancer patients. The advanced technology expanded upper extremity post-mastectomy treatment options for patients with lymphedema. The oncology devices market covered in this report is segmented by device type into brachytherapy devices; endoscopic devices. It is also segmented by therapy into chemotherapy; hormone therapy; biotherapy/immunotherapy; radiation therapy and by end user into hospitals; cancer research institutes; others. A growing number of cancer cases across the globe is anticipated to boost the demand for the oncology devices market. Cancer is a major health problem across the globe and is the second leading cause of death in the USA. The increasing incidence of cancer is contributing to the surge in the demand for oncology devices to treat cancer patients. The four most common types of cancer globally are prostate, lung, bowel, and female breast cancer, accounting for 43% of all the new cancer cases. According to the American Cancer Society, there were 1.7 million new cases and 0.6 million cancer deaths in 2019 in the USA. Therefore, the rise in cancer incidence is anticipated to boost the demand for the oncology drugs market. The low per capita expenditure on healthcare in developing countries is anticipated to limit the growth of the oncology devices market. The per capital expenditure on healthcare is very low in emerging economies such as China, India, and Indonesia as compared to developed nations. Key Topics Covered:

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Eckert & Ziegler BEBIG

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Eckert & Ziegler BEBIG is included in 4 Expert Collections, including Pharma Startups.

P

Pharma Startups

6,549 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

C

Cancer Therapeutics

1,179 items

Pharmaceutical and biotechnology companies with cancer therapy drug candidates.

C

Cancer

3,592 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

M

Medical Devices

3,009 items

Companies that have been granted at least 1 510(k)s by the FDA since 2014. Companies tagged as #FDA510(K)

Eckert & Ziegler BEBIG Patents

Eckert & Ziegler BEBIG has filed 5 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

5/13/2014

12/23/2014

Radiation therapy, Medical physics, Radioactivity, Radiobiology, Molecular biology

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

5/13/2014

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

12/23/2014

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Radiation therapy, Medical physics, Radioactivity, Radiobiology, Molecular biology

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.